Volatility in the stock market is expected to rise amid increasing coronavirus cases across the world. Among the uncertainty, TipRanks brings you the latest analyst action...
Doubts emerge over AZ’s ‘outdated’ US vaccine trial data...
Ocugen (OCGN) has been one of 2021’s biggest and unlikeliest success stories. The eye disease specialist has shifted its focus to getting another Covid-19 vaccine to market.\
4 Penny Stocks To Watch Right Now The post Hot Penny Stocks To Add To Your Watch List This Week appeared first on Penny Stocks to...
The savvy investor knows that the best time to buy is when a stock is priced low – it’s just the old game of ‘buy low...
Shares of Catalyst Pharma rose more than 3% in the pre-market session after the commercial-stage biopharmaceutical company announced its stock repurchase program of up to $40...
Janssen, a Johnson & Johnson (JNJ) company, announced that the US Food and Drug Administration (FDA) has approved its PONVORY (ponesimod) therapy as a first-of-its-kind oral...
Enova International, a financial technology company, has agreed to buy Chicago-based Pangea Universal Holdings, a platform offering mobile international money transfer services. The financial terms of...
One Year Ago: 'Gather In Crowds', 'Masks Are Useless', 'Only A Few Percent Are Vulnerable' Amid the always-fearmongering, always-pessimistic, always-more-control-demanded, (and almost always wrong) daily headlines...
One day after the EMA left the door open to the possibility that the AstraZeneca-Oxford COVID jab might have harmful side effects, researchers in Germany find...
Merck’s checkpoint inhibitor Keytruda and Eisai’s tyrosine kinase inhibitor Lenvima significantly improved progression-free survival in advanced endometrial cancer in the Phase III KEYNOTE-775/Study 309 trial.
The U.S. Senate confirmed Xavier Becerra as Secretary of the Department of Health and Human Services (HHS) in a 50-49 vote.
Penny Stocks News Sparks Big Momentum In These Companies
Todavía no existe una cura rápida, pero varios tratamientos están ayudando a los pacientes a sobrevivir al COVID-19 y permanecer fuera del hospital por completo.
Kiniksa Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved its ARCALYST injection therapy as a first-of-its-kind treatment for adults and children 12...
Clinical trial at Cedars-Sinai suggests injections of female hormone may reduce disease severity in certain male patients Credit: Cedars-Sinai LOS ANGELES (March 18, 2021) — COVID-19...
Are These Penny Stocks on Your March Watchlist? The post Hot Penny Stocks On Robinhood To Watch Before Next Month appeared first on Penny Stocks to...
These 4 Top Biotech Penny Stocks Are Turning Heads...
Axcella Health dipped 3.8% to close at $5.57 on March 17 after the clinical-stage biotechnology company posted a larger-than-expected loss in the fourth quarter. Axcella Health...
Family Oddball, and a New Class of Safe Oral Autoimmune & Inflammatory Disease Treatment with Blockbuster Potential By Jeb Keiper, CEO of Nimbus Therapeutics, as part...
Best Penny Stocks To Buy With Your Stimulus Check? 4 Names To Watch
In an effort to find new treatments for COVID-19 that could be made available quickly, researchers searched through FDA-approved drugs to identify candidates that may inhibit...
GSK and Medicago’s plant-based COVID-19 shot heads into phase 3 trial
Surgalign Holdings disappointed with its 4Q performance as the company reported a wider-than-expected loss. Further, its FY21 revenue outlook also fell short of analysts' estimates. Shares...
3 Biotech Penny Stocks To Buy For Under $3 On Robinhood In March
The Race for Vaccine Against COVID-19 Variants Heats Up...
Top Penny Stocks Under $3 To Watch This Week
Analysts Have These Penny Stocks At 'Buy' Right Now But Do You Agree? The post Hot Penny Stocks To Buy According To 4 Analysts & Targets...
The success of Covid-19 vaccines based on messenger RNA (mRNA) is smoothing the way for using the novel technology not only in other vaccines, but possibly...
Best Penny Stocks To Buy Now? 5 For Your Watch List